Centyl K 2.5 mg/573 mg modified-release tablets

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

Bendroflumethiazide; Potassium chloride

Disponível em:

Leo Laboratories Limited

Código ATC:

C03AB; C03AB01

DCI (Denominação Comum Internacional):

Bendroflumethiazide; Potassium chloride

Dosagem:

2.5/573 milligram(s)

Forma farmacêutica:

Modified-release tablet

Tipo de prescrição:

Product subject to prescription which may be renewed (B)

Área terapêutica:

Thiazides and potassium in combination; bendroflumethiazide and potassium

Status de autorização:

Marketed

Data de autorização:

1978-04-01

Folheto informativo - Bula

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
CENTYL
® K 2.5 MG/573 MG MODIFIED-RELEASE TABLETS
bendroflumethiazide/potassium chloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See section 4.

In this leaflet,
Centyl
®
K modified-release tablets will be called Centyl
K.
WHAT IS IN THIS LEAFLET
1.
What Centyl
®
K is and what it is used for
2.
What you need to know before you take Centyl
®
K
3.
How to take Centyl
®
K
4.
Possible side effects
5.
How to store Centyl
®
K
6.
Contents of the pack and other information
1.
WHAT CENTYL
® K IS AND WHAT IT IS USED FOR
Centyl
K
contains
two
different
types
of
active
substances.
One
is
called
bendroflumethiazide, it is a diuretic (water tablet). The other active
substance is called
potassium chloride. It is a potassium supplement. The two medicines
work at the
same time in different ways.
Centyl K works by removing any excess water from your body. It will
make you go to
the toilet more. This means you will also lose potassium from your
body. The
potassium chloride in Centyl K
is a supplement to replace some of the potassium you
may lose.
Centyl K is used to treat:
• Oedema which occurs as a result of heart, kidney or liver
problems. Oedema means
that there is too much water in your body. Oedema can cause symptoms
such as
swollen ankles or trouble breathing.
• High blood pressure (hypertension). Your doctor may also decide to
give you other
blood pressure lowering medicines as well as this medicine.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CENTYL
® K
DO NOT TAKE
CENTYL K

If
y

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Centyl K 2.5 mg/573 mg modified-release tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.5mg of bendroflumethiazide and 573mg of
potassium chloride.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Modified-release tablet
Green, film-coated, oval shaped tablet.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Centyl K is indicated as a diuretic:
• In the management of oedema such as that which arises from
cardiac, renal or hepatic origin.
• In the management of hypertension alone or in combination with
other antihypertensives.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Hypertension:_
1-2 tablets once daily.
_Oedema:_
Initial dosage 1-4 tablets once daily.
Maintain with 1-2 tablets daily.
Method of administration
For oral administration.
Centyl K should be taken in the morning to avoid nocturia.
The tablets should be taken with or after meals with at least a full
glass of water or other fluid.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
Addison’s disease.
Severe renal impairment or anuria (see section 4.4).
Severe hepatic impairment (see section 4.4).
Established arthritis urica.
Severe dehydration electrolyte imbalance including hypercalcaemia,
hyponatraemia, hyperchloraemia,
hyperkalaemia or any situation which might lead to hyperkalaemia.
Ulcer or obstruction of the gastrointestinal tract.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__